PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
RATIONALE: PV701 may be able to kill tumor cells while leaving normal cells undamaged. PURPOSE: Phase I trial to study the effectiveness of PV701 in treating patients who have advanced or recurrent ovarian epithelial, fallopian tube, primary peritoneal, colorectal, or other cancer found primarily within the peritoneal cavity.
创建时间：
2003-01-15
